0,910  0,004  Eye irritation, high
0,839  0,004  Skin irritative effect
0,800  0,005  GST A substrate
0,805  0,015  Antiinflammatory
0,771  0,005  Antipsoriatic
0,767  0,005  Sensitization
0,752  0,009  Carcinogenic
0,751  0,010  TNF expression inhibitor
0,742  0,002  GABA C receptor agonist
0,736  0,003  Alpha-N-acetylglucosaminidase inhibitor
0,743  0,019  Caspase 9 stimulant
0,727  0,005  AR expression inhibitor
0,702  0,005  Immunomodulator
0,692  0,011  Antihypercholesterolemic
0,691  0,009  Mutagenic
0,695  0,016  Teratogen
0,688  0,016  Embryotoxic
0,659  0,009  CTGF expression inhibitor
0,679  0,034  Apoptosis agonist
0,647  0,008  Antiosteoporotic
0,646  0,010  Bone diseases treatment
0,629  0,002  Succinate dehydrogenase inhibitor
0,631  0,008  Antipruritic, allergic
0,629  0,010  Immunosuppressant
0,622  0,003  Tyrosine 3 hydroxylase inhibitor
0,614  0,003  Interleukin 2 agonist
0,632  0,025  CYP3A4 substrate
0,613  0,007  Hypoglycemic
0,611  0,006  Platelet antagonist
0,610  0,009  Lipoprotein disorders treatment
0,598  0,003  Alcohol oxidase inhibitor
0,603  0,009  Apoptosis antagonist
0,613  0,025  Antidiabetic
0,613  0,025  Cyclophilin D inhibitor
0,601  0,017  Respiratory analeptic
0,589  0,007  FMO1 substrate
0,590  0,012  Antioxidant
0,584  0,009  Antifungal
0,572  0,005  Antiulcerative
0,570  0,003  Corneal wound healing stimulator
0,577  0,022  Aldehyde oxidase inhibitor
0,568  0,014  Cardioprotectant
0,552  0,004  Platelet adhesion inhibitor
0,563  0,019  Antiallergic
0,538  0,006  Carcinogenic, group 3
0,547  0,016  Hepatic disorders treatment
0,548  0,018  Analeptic
0,523  0,002  Alcohol dehydrogenase substrate
0,523  0,004  Gout treatment
0,529  0,010  Hypolipemic
0,539  0,022  Vasodilator, peripheral
0,542  0,029  CYP2C9 substrate
0,532  0,020  Histamine release inhibitor
0,531  0,018  GABA C receptor rho-3 antagonist
0,531  0,020  CYP1A2 substrate
0,547  0,038  Transcription factor NF kappa B inhibitor
0,515  0,021  Chemoprotective
0,502  0,016  Nitric oxide antagonist
0,511  0,026  CYP2C19 substrate
0,488  0,014  DNA synthesis inhibitor
0,490  0,017  Free radical scavenger
0,477  0,006  Antiacne
0,482  0,014  UGT2B4 substrate
0,488  0,020  Cardiovascular analeptic
0,505  0,039  Antibacterial
0,466  0,002  Fumarate hydratase inhibitor
0,492  0,030  Thioredoxin glutathione reductase inhibitor
0,462  0,005  Liver fibrosis treatment
0,481  0,025  Radioprotector
0,462  0,006  Sodium/bile acid cotransporter inhibitor
0,483  0,027  Ulceration
0,458  0,005  GST P1-1 substrate
0,460  0,008  Abortion inducer
0,454  0,004  Glutamate dehydrogenase inhibitor
0,463  0,013  Peroxidase inhibitor
0,479  0,031  5 Hydroxytryptamine release stimulant
0,453  0,005  Acaricide
0,453  0,006  NOS3 expression enhancer
0,474  0,033  Antithrombotic
0,443  0,003  Ferrochelatase inhibitor
0,457  0,019  Antiparasitic
0,451  0,015  Antihypoxic
0,451  0,015  UDP-glucuronosyltransferase substrate
0,449  0,015  Radiosensitizer
0,435  0,004  Carcinogenic, group 1
0,452  0,022  ICAM1 expression inhibitor
0,445  0,025  Interleukin antagonist
0,422  0,004  Antiprotozoal (Coccidial)
0,435  0,018  Antihypertriglyceridemic
0,421  0,004  Uric acid excretion stimulant
0,434  0,018  Vasodilator
0,427  0,012  FMO3 substrate
0,436  0,021  Antineoplastic (lymphoma)
0,439  0,028  Cytostatic
0,424  0,014  Anesthetic general
0,418  0,009  GST M1-1 substrate
0,412  0,004  ABCA1 expression enhancer
0,413  0,008  Protein-tyrosine phosphatase inhibitor
0,454  0,050  5 Hydroxytryptamine release inhibitor
0,443  0,042  Stroke treatment
0,408  0,009  Antipruritic, non-allergic
0,412  0,015  Antihelmintic
0,414  0,017  Interleukin agonist
0,397  0,004  Porphobilinogen synthase inhibitor
0,417  0,024  Superoxide dismutase inhibitor
0,407  0,015  Antimutagenic
0,419  0,031  UGT1A9 substrate
0,388  0,002  Aconitate hydratase inhibitor
0,393  0,009  Protein kinase stimulant
0,427  0,044  Cholesterol antagonist
0,395  0,014  Non-steroidal antiinflammatory agent
0,378  0,003  Growth stimulant
0,378  0,006  Gastrin inhibitor
0,440  0,069  Antineoplastic (breast cancer)
0,405  0,035  Cytotoxic
0,392  0,026  UGT1A6 substrate
0,391  0,030  DNA damaging
0,380  0,022  Flavin-containing monooxygenase substrate
0,371  0,013  Hair growth stimulant
0,362  0,005  Excitatory amino acid transporter EAAC1 inhibitor
0,371  0,015  UGT2B7 substrate
0,359  0,003  Glutamate decarboxylase inhibitor
0,374  0,019  P-glycoprotein inhibitor
0,361  0,007  Protein-tyrosine phosphatase 1B inhibitor
0,400  0,050  Immunostimulant
0,365  0,021  UGT1A1 substrate
0,368  0,025  Antineoplastic (lymphocytic leukemia)
0,375  0,033  Proliferative diseases treatment
0,356  0,015  UGT1A3 substrate
0,363  0,022  5 Hydroxytryptamine uptake stimulant
0,348  0,008  Phospholipase A2 inhibitor
0,349  0,014  Interferon gamma antagonist
0,348  0,015  VCAM1 expression inhibitor
0,337  0,006  Interleukin 4 antagonist
0,333  0,004  Triose-phosphate isomerase inhibitor
0,338  0,010  Insulin sensitizer
0,332  0,005  Catalase inhibitor
0,335  0,008  Antineoplastic antibiotic
0,393  0,066  Antileukemic
0,373  0,046  NOS3 expression inhibitor
0,360  0,035  Tumour necrosis factor alpha release inhibitor
0,329  0,005  ATPase inhibitor
0,346  0,023  UGT1A4 substrate
0,334  0,011  Neurotrophic factor enhancer
0,326  0,005  Adenylate kinase inhibitor
0,361  0,041  Antidiabetic (type 2)
0,320  0,003  Transcription factor AP-1 inhibitor
0,334  0,022  Hepatoprotectant
0,325  0,013  Antihelmintic (Nematodes)
0,317  0,010  DNA polymerase I inhibitor
0,312  0,006  Histidine decarboxylase inhibitor
0,314  0,008  Expectorant
0,324  0,017  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,356  0,050  Antineoplastic (brain cancer)
0,340  0,036  Vascular (periferal) disease treatment
0,347  0,044  NOS2 expression inhibitor
0,341  0,039  Antineoplastic (small cell lung cancer)
0,308  0,009  Carcinogenic, group 2B
0,353  0,056  Antineoplastic (ovarian cancer)
0,343  0,047  Antineoplastic (cervical cancer)
0,295  0,005  Phosphofructokinase-1 inhibitor
0,299  0,010  Cell wall synthesis inhibitor
0,346  0,059  CYP2D6 substrate
0,310  0,023  DNA methyltransferase I inhibitor
0,393  0,107  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,297  0,012  Antihyperlipoproteinemic
0,302  0,017  UGT2B15 substrate
0,290  0,007  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,286  0,003  NMDA receptor agonist
0,284  0,002  Retinoid X beta receptor agonist
0,287  0,005  Arylamine N-Acetyltransferase substrate
0,323  0,042  Antineoplastic (liver cancer)
0,319  0,039  Chemopreventive
0,284  0,007  UGT2B10 substrate
0,302  0,034  Septic shock treatment
0,327  0,059  Lipoxygenase inhibitor
0,278  0,014  UGT2B9 substrate
0,269  0,005  Vanilloid agonist
0,293  0,030  DNA methylase inhibitor
0,270  0,009  Antieczematic
0,297  0,037  Antiparkinsonian, rigidity relieving
0,272  0,011  Uterine stimulant
0,275  0,016  Glutathione S-transferase substrate
0,262  0,004  Antiviral (Papilloma)
0,261  0,004  Arachidonic acid antagonist
0,264  0,008  Antispirochetal
0,314  0,060  Antineoplastic (osteosarcoma)
0,259  0,005  Peroxisome proliferator-activated receptor gamma agonist
0,274  0,022  Antiischemic, cerebral
0,326  0,074  Prostate cancer treatment
0,250  0,003  Acyl-CoA dehydrogenase inhibitor
0,249  0,003  Antidote, mercury
0,274  0,030  Pneumotoxic
0,257  0,014  Cystathionine beta-synthase inhibitor
0,279  0,037  RNA-directed DNA polymerase inhibitor
0,267  0,026  Skeletal muscle relaxant
0,265  0,024  Lipid peroxidase inhibitor
0,245  0,005  Vanilloid 1 agonist
0,243  0,004  GST T1-1 substrate
0,256  0,018  Interleukin 1 antagonist
0,288  0,051  Pyruvate kinase inhibitor
0,242  0,005  Prostaglandin EP2 antagonist
0,354  0,117  Antiarthritic
0,243  0,007  GABA C receptor antagonist
0,250  0,015  Cell adhesion inhibitor
0,265  0,030  CYP2B6 inhibitor
0,240  0,005  Keratolytic
0,240  0,005  Actinic keratosis treatment
0,244  0,010  Microtubule formation inhibitor
0,249  0,018  Aldehyde dehydrogenase inhibitor
0,241  0,010  Retinopathy treatment
0,234  0,004  Biliverdin reductase inhibitor
0,253  0,024  Phospholipase C inhibitor
0,252  0,023  Antidote
0,310  0,082  Calcium channel activator
0,239  0,014  UDP-glucose 4-epimerase inhibitor
0,236  0,012  Antirickettsial
0,253  0,029  Restenosis treatment
0,285  0,062  Antipyretic
0,294  0,072  Spasmolytic
0,229  0,009  NADH dehydrogenase inhibitor
0,287  0,067  Insulysin inhibitor
0,228  0,009  Aldehyde dehydrogenase substrate
0,242  0,025  LDLR expression enhancer
0,277  0,062  Antidiabetic symptomatic
0,248  0,033  Antiviral (Hepatitis)
0,219  0,006  Carbamoyl phosphate synthetase inhibitor
0,246  0,034  Amyloid beta precursor protein antagonist
0,350  0,138  Antineoplastic (solid tumors)
0,231  0,020  SULT1A3 substrate
0,219  0,007  Adenylate cyclase stimulant
0,241  0,030  Melanin inhibitor
0,237  0,026  Antiviral (Hepatitis C)
0,217  0,006  Interleukin 2 antagonist
0,226  0,018  GABA C receptor rho-2 antagonist
0,258  0,050  Antihypotensive
0,258  0,050  Antiviral (HIV)
0,215  0,008  TRPA1 agonist
0,213  0,006  GABA C receptor rho-1 antagonist
0,212  0,006  Prostaglandin antagonist
0,226  0,022  Aldose reductase substrate
0,230  0,027  Monophenol monooxygenase inhibitor
0,209  0,007  Argininosuccinate synthase inhibitor
0,205  0,003  Ca2+-transporting ATPase inhibitor
0,242  0,043  Muscle relaxant
0,203  0,003  Antiviral (Hepatitis A)
0,200  0,003  Cyclophilin A inhibitor
0,206  0,010  Creatine kinase inhibitor
0,217  0,021  5-Lipoxygenase inhibitor
0,222  0,028  Antidiabetic (type 1)
0,310  0,115  Atherosclerosis treatment
0,196  0,003  Retinoic acid beta receptor agonist
0,239  0,051  Antiviral (Influenza)
0,191  0,003  Retinoic acid alpha receptor agonist
0,212  0,024  Cholesterol synthesis inhibitor
0,222  0,036  Antipruritic
0,232  0,047  Nitric-oxide synthase stimulant
0,285  0,101  Vasodilator, coronary
0,198  0,014  Mucolytic
0,185  0,002  Retinoid X gamma receptor agonist
0,185  0,003  Retinoic acid receptor agonist
0,209  0,028  Antianemic
0,188  0,008  Phenylalanine 4-hydroxylase inhibitor
0,181  0,002  Glucose-6-phosphate isomerase inhibitor
0,200  0,021  Aminopeptidase B inhibitor
0,178  0,002  Kainate receptor agonist
0,202  0,026  Alkylator
0,195  0,019  SULT1A1 substrate
0,190  0,014  Antihelmintic (Fasciola)
0,236  0,062  Peptidyltransferase inhibitor
0,178  0,004  ATPase (Vacuolar H+) inhibitor
0,202  0,029  Mannose-6-phosphate isomerase inhibitor
0,186  0,015  HIV-1 integrase (Overall Integration) inhibitor
0,203  0,033  Neurotensin receptor agonist
0,185  0,017  Contraceptive female
0,170  0,003  Exportin-1 inhibitor
0,208  0,042  Amylase inhibitor
0,174  0,008  UGT2B11 substrate
0,172  0,007  Ornithine decarboxylase inhibitor
0,172  0,006  Lanosterol 14 alpha demethylase inhibitor
0,181  0,016  Gastric antisecretory
0,242  0,079  Myocardial infarction treatment
0,184  0,021  Coagulant
0,205  0,042  Diuretic
0,260  0,098  Antiischemic
0,180  0,020  UGT2B1 substrate
0,172  0,012  DOPA decarboxylase inhibitor
0,193  0,034  Antifungal enhancer
0,197  0,038  Insulin secretagoues
0,195  0,038  Genotoxic
0,177  0,020  Interleukin 8 antagonist
0,200  0,043  Antiparkinsonian, tremor relieving
0,173  0,017  Antiviral (Influenza B)
0,209  0,053  Macular degeneration treatment
0,207  0,052  Lipocortins synthesis antagonist
0,167  0,014  Electrolyte absorption antagonist
0,158  0,008  Thioredoxin reductase inhibitor
0,158  0,009  Interferon agonist
0,160  0,011  Aminopeptidase I inhibitor
0,165  0,017  Carcinogenic, group 2A
0,166  0,021  Heat shock protein 70 antagonist
0,158  0,015  Antifungal (Pneumocystis)
0,165  0,023  Antineoplastic, alkylator
0,169  0,028  Shock treatment
0,159  0,018  Antibiotic
0,211  0,074  Platelet aggregation inhibitor
0,168  0,030  Antiviral (Poxvirus)
0,152  0,015  Cell adhesion molecule inhibitor
0,162  0,025  Carbonic anhydrase III inhibitor
0,164  0,027  Choleretic
0,148  0,012  Glutathione S-transferase inhibitor
0,147  0,012  NAT1 substrate
0,144  0,010  Ornithine carbamoyltransferase inhibitor
0,203  0,069  Wound healing agent
0,197  0,063  Antieczematic atopic
0,180  0,047  Anesthetic
0,136  0,003  Retinoid X alpha receptor agonist
0,184  0,051  Interleukin 6 antagonist
0,153  0,021  Prolactin inhibitor
0,140  0,008  Glycine receptor agonist
0,134  0,003  Retinoid X receptor agonist
0,158  0,027  Photosensitizer
0,135  0,005  Antiviral (Parainfluenza)
0,215  0,086  Antiviral (West Nile virus)
0,133  0,005  Kainate receptor antagonist
0,158  0,031  Xanthine oxidase inhibitor
0,160  0,034  Antineoplastic antimetabolite
0,156  0,030  NAT2 substrate
0,244  0,118  Caspase 3 stimulant
0,170  0,045  Antiseptic
0,129  0,005  Squalene synthetase inhibitor
0,166  0,042  Toll-Like receptor 2 antagonist
0,181  0,058  Aldehyde oxidase substrate
0,144  0,021  Anabolic
0,124  0,002  Retinoic acid receptor antagonist
0,150  0,028  Sulfotransferase substrate
0,127  0,005  Antitreponemal
0,177  0,056  Catenin beta inhibitor
0,126  0,005  Glutamate (mGluR6) antagonist
0,131  0,010  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,163  0,042  Sphingosine 1-phosphate receptor 5 antagonist
0,124  0,002  Retinoic acid alpha receptor antagonist
0,149  0,028  Caspase 3 inhibitor
0,123  0,002  Retinoic acid gamma receptor agonist
0,225  0,104  Amyotrophic lateral sclerosis treatment
0,132  0,012  GABA aminotransferase inhibitor
0,118  0,001  Retinoid X gamma receptor antagonist
0,130  0,014  Leukotriene synthesis inhibitor
0,158  0,042  Cyclooxygenase 3 inhibitor
0,120  0,004  Kainate receptor 2 antagonist
0,174  0,060  Antiviral (Herpes)
0,268  0,156  CYP2C19 inhibitor
0,172  0,060  Neuropathy treatment
0,167  0,055  Raynaud's phenomenon treatment
0,114  0,004  Lysophosphatidic acid 3 receptor antagonist
0,123  0,014  Hyperparathyroidism treatment
0,131  0,024  Paget's disease treatment
0,210  0,103  Neuropeptide Y2 antagonist
0,136  0,028  Folate antagonist
0,111  0,005  SULT2A1 substrate
0,112  0,008  Antidote, organophosphates
0,195  0,091  Antialcoholic
0,119  0,015  Leukotriene antagonist
0,119  0,016  Granulocyte macrophage colony stimulating factor agonist
0,118  0,016  HIV-1 integrase inhibitor
0,148  0,047  Cathepsin H inhibitor
0,122  0,022  Antifungal (Candida)
0,159  0,061  Thiol protease inhibitor
0,149  0,050  Retinoprotector
0,108  0,011  Peroxisome proliferator-activated receptor alpha agonist
0,116  0,019  Na+ K+ transporting ATPase inhibitor
0,102  0,006  Thromboxane synthase inhibitor
0,101  0,005  Anesthetic inhalation
0,121  0,027  Antiviral (Rhinovirus)
0,135  0,042  Chelator
0,196  0,103  Antiprotozoal (Leishmania)
0,212  0,119  Transcription factor STAT3 inhibitor
0,097  0,004  Lysophosphatidic acid 2 receptor antagonist
0,108  0,016  Aldose reductase inhibitor
0,095  0,003  Sodium-dependent vitamin C transporter 2 inhibitor
0,156  0,065  Antineoplastic (carcinoma)
0,102  0,010  Antiviral (Herpesvirus 3, Human)
0,095  0,004  Leukotriene B4 receptor 1 antagonist
0,144  0,053  Antihelmintic (Trematoda)
0,120  0,029  Carbonic anhydrase VI inhibitor
0,147  0,056  Farnesoid X receptor antagonist
0,095  0,005  Prostaglandin agonist
0,094  0,004  Membrane dipeptidase inhibitor
0,092  0,003  Retinoic acid receptor gamma antagonist
0,107  0,018  Estrogen-related receptor beta agonist
0,092  0,003  Glutamate (mGluR8) agonist
0,091  0,003  Retinoic acid beta receptor antagonist
0,150  0,062  Contraceptive
0,103  0,016  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,111  0,024  Glycine receptor antagonist
0,092  0,006  Prostaglandin EP3 antagonist
0,141  0,054  Sphingosine 1-phosphate receptor 2 antagonist
0,227  0,140  Antineoplastic (lung cancer)
0,092  0,006  Dihydroorotate oxidase inhibitor
0,098  0,012  Thromboxane antagonist
0,183  0,097  5 Hydroxytryptamine 3E antagonist
0,097  0,011  Leukotriene B4 antagonist
0,101  0,016  Vanilloid 4 agonist
0,101  0,016  NMDA receptor glycine site agonist
0,127  0,042  Myasthenia Gravis treatment
0,087  0,004  Kainate receptor 1 antagonist
0,091  0,009  Andropause treatment
0,114  0,031  Phosphodiesterase 6D inhibitor
0,126  0,044  Estrogen antagonist
0,098  0,017  Purinergic P2X1 antagonist
0,098  0,017  Peroxisome proliferator-activated receptor gamma antagonist
0,094  0,014  Glutamate (mGluR7) antagonist
0,090  0,010  Thromboxane A2 antagonist
0,082  0,003  Retinoid X receptor antagonist
0,097  0,018  GABA B receptor agonist
0,159  0,080  Muscular dystrophy treatment
0,102  0,023  Narcotic antagonist
0,234  0,156  Inflammatory Bowel disease treatment
0,122  0,044  Electron transport complex I inhibitor
0,152  0,074  Cytidine deaminase inhibitor
0,164  0,086  Phobic disorders treatment
0,177  0,100  VEGF expression inhibitor
0,114  0,038  Tourette's syndrome treatment
0,114  0,039  Alcohol dehydrogenase inhibitor
0,093  0,019  Protease 3C (Human rhinovirus) inhibitor
0,115  0,040  Interleukin 1 beta converting enzyme inhibitor
0,131  0,057  Proteasome inhibitor
0,092  0,018  Neuraminidase inhibitor
0,101  0,028  D-Ala-D-Ala ligase inhibitor
0,089  0,016  Protein 50S ribosomal subunit inhibitor
0,105  0,033  Inducible nitric-oxide synthase inhibitor
0,221  0,149  Multiple sclerosis treatment
0,106  0,034  Glutamate release inhibitor
0,078  0,007  Nicotinic acid receptor agonist
0,151  0,081  Thrombolytic
0,074  0,004  Kynurenine 3 monooxygenase inhibitor
0,096  0,027  Sphingosine 1-phosphate receptor 4 agonist
0,072  0,003  Retinoid X alpha receptor antagonist
0,071  0,002  Retinoid X beta receptor antagonist
0,092  0,023  Anticholelithogenic
0,096  0,028  HIV-1 integrase (3'-Processing) inhibitor
0,090  0,022  Endocannabinoid uptake inhibitor
0,132  0,065  Antibacterial (Helicobacter pylori)
0,179  0,112  Cyclic AMP phosphodiesterase inhibitor
0,087  0,021  Antidote, heavy metal
0,113  0,047  Sphingomyelinase inhibitor
0,136  0,071  CNS active muscle relaxant
0,091  0,026  HIV-1 integrase (Strand Transfer) inhibitor
0,085  0,020  Caspase 9 inhibitor
0,082  0,018  MDM2 inhibitor
0,074  0,010  Pregnane X receptor antagonist
0,116  0,052  Mediator release inhibitor
0,131  0,068  Antihemorrhagic
0,068  0,005  Prostaglandin D2 antagonist
0,076  0,013  5-Alpha-reductase inhibitor
0,101  0,038  Antileprosy
0,076  0,013  DNA helicase inhibitor
0,084  0,021  Interferon inducer
0,125  0,063  Antiprotozoal (Amoeba)
0,155  0,093  3C-like protease (Human coronavirus) inhibitor
0,075  0,014  Alpha-mannosidase inhibitor
0,093  0,032  CDC25A inhibitor
0,165  0,104  Psychostimulant
0,097  0,037  3C-Like protease (SARS coronavirus) inhibitor
0,098  0,039  Carbonic anhydrase XIII inhibitor
0,081  0,022  Antimycoplasmal
0,063  0,004  Leukotriene B4 receptor 2 antagonist
0,124  0,065  Sphingosine 1-phosphate receptor 4 antagonist
0,130  0,072  Skin whitener
0,102  0,045  Bile acid receptor antagonist
0,141  0,084  Antidiarrheal
0,120  0,063  Antiprotozoal (Babesia)
0,130  0,073  Antiprotozoal (Trichomonas)
0,070  0,014  Leukotriene C antagonist
0,078  0,024  Human rhinovirus A protease inhibitor
0,171  0,118  Antiglaucomic
0,083  0,030  Phospholipase D inhibitor
0,142  0,089  Pulmonary hypertension treatment
0,074  0,022  Prostaglandin E2 antagonist
0,060  0,008  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,109  0,057  Protease inhibitor
0,136  0,084  Pregnane X receptor agonist
0,106  0,055  Anticataract
0,057  0,006  Prostaglandin D2 agonist
0,116  0,065  Interleukin 1b antagonist
0,050  0,001  Immunosuppressant Cyclosporine-like
0,108  0,058  Urease inhibitor
0,071  0,021  Antimetabolite
0,083  0,034  Carbonic anhydrase VA inhibitor
0,103  0,055  Nitric-oxide synthase inhibitor
0,063  0,015  Factor III inhibitor
0,053  0,006  HMG CoA reductase inhibitor
0,076  0,028  Neuraminidase (influenza) inhibitor
0,064  0,017  Glutamate (mGluR group III) agonist
0,063  0,015  Thymidylate synthase inhibitor
0,174  0,127  Antineoplastic (non-small cell lung cancer)
0,062  0,015  Mannosidase inhibitor
0,061  0,014  Dopamine beta hydroxylase inhibitor
0,117  0,070  Topoisomerase II inhibitor
0,086  0,040  Cathepsin G inhibitor
0,057  0,011  GABA uptake inhibitor
0,150  0,105  Sedative
0,125  0,081  Bone formation stimulant
0,125  0,080  Cocaine dependence treatment
0,058  0,013  Guanylate cyclase inhibitor
0,197  0,153  Antimycobacterial
0,175  0,130  Antineoplastic (renal cancer)
0,073  0,030  NMDA 2C receptor antagonist
0,079  0,036  Carbonic anhydrase V inhibitor
0,065  0,023  Integrin antagonist
0,047  0,004  Prostaglandin F2 alpha agonist
0,070  0,028  Carbonic anhydrase VB inhibitor
0,048  0,006  Prostaglandin EP2 agonist
0,049  0,008  GABA transporter 3 inhibitor
0,079  0,038  S-adenosyl-L-methionine decarboxylase inhibitor
0,066  0,025  Postcoital contraceptive
0,087  0,047  Glutamate receptor agonist
0,191  0,151  Transcription factor STAT inhibitor
0,179  0,140  Antiprotozoal (Trypanosoma)
0,059  0,020  Toll-Like receptor 2 agonist
0,043  0,005  Lysophosphatidic acid receptor 1 agonist
0,052  0,014  Arginase inhibitor
0,085  0,047  NAD(P)H dehydrogenase (quinone) inhibitor
0,112  0,074  Autism spectrum disorders treatment
0,044  0,006  Calcium-independent phospholipase A2 inhibitor
0,069  0,032  Carbonic anhydrase stimulant
0,053  0,016  GABA B receptor antagonist
0,082  0,045  Estrogen receptor alpha antagonist
0,042  0,005  Prostaglandin H2 antagonist
0,044  0,007  Glutamate (mGluR3) agonist
0,093  0,056  Restless leg syndrome treatment
0,044  0,008  Methionyl aminopeptidase 2 inhibitor
0,049  0,013  Glutamate (mGluR3) antagonist
0,150  0,114  Antineoplastic (bone cancer)
0,046  0,011  Glutamate (mGluR8) antagonist
0,123  0,087  Antineoplastic (squamous cell carcinoma)
0,046  0,011  Integrin alpha1beta1 antagonist
0,039  0,005  Nicotinic acid receptor 2 antagonist
0,051  0,017  Angiotensin AT1 receptor antagonist
0,151  0,117  Cardiodepressant
0,047  0,013  Leukotriene C4 antagonist
0,106  0,074  Acetylcholine release stimulant
0,051  0,019  Glutamate (mGluR4) antagonist
0,042  0,010  Prostaglandin EP4 antagonist
0,099  0,068  Carbonic anhydrase XV inhibitor
0,088  0,057  Interleukin 5 antagonist
0,037  0,006  Prostaglandin EP4 agonist
0,069  0,039  CDC25B inhibitor
0,038  0,008  Prostaglandin E2 agonist
0,044  0,015  Peroxisome proliferator-activated receptor delta agonist
0,044  0,014  VLA-4 antagonist
0,050  0,022  AICAR transformylase inhibitor
0,048  0,019  Dopamine D5 agonist
0,030  0,002  Calcineurin inhibitor
0,042  0,014  Glutamate (mGluR4) agonist
0,050  0,023  Geranyltranstransferase inhibitor
0,049  0,022  Glutamate (mGluR group III) antagonist
0,075  0,048  Potassium channel (Tandem pore domain) blocker
0,034  0,007  Glutamate (mGluR1a) agonist
0,031  0,004  Carbonic anhydrase VIII inhibitor
0,031  0,004  Carbonic anhydrase X inhibitor
0,031  0,005  Isoleucine-tRNA ligase inhibitor
0,056  0,030  Heparanase inhibitor
0,190  0,164  Hypoxia-inducible factor 1 alpha inhibitor
0,039  0,013  Methionyl aminopeptidase 1 inhibitor
0,131  0,106  Growth hormone agonist
0,041  0,015  Free fatty acid receptor 1 antagonist
0,028  0,003  Glutamate (mGluR6) agonist
0,039  0,014  ATP citrate lysase inhibitor
0,078  0,053  Macrophage migration inhibitory factor inhibitor
0,036  0,012  NMDA 2D receptor antagonist
0,036  0,012  Lysine carboxypeptidase inhibitor
0,032  0,008  Vanilloid 2 agonist
0,120  0,096  Neurotrophic factor
0,052  0,028  Adenosine deaminase inhibitor
0,060  0,036  Ryanodine receptor antagonist
0,028  0,005  Neuraminidase (Influenza B) inhibitor
0,103  0,080  Antiviral (Coronavirus)
0,103  0,080  Antiviral (SARS coronavirus)
0,077  0,054  Nicotinic alpha4beta2 receptor antagonist
0,147  0,124  Angiogenesis stimulant
0,124  0,101  Antiviral (Influenza A)
0,129  0,106  Hexokinase inhibitor
0,039  0,017  Tryptophan 5 hydroxylase inhibitor
0,027  0,005  Vesicular glutamate transport inhibitor
0,044  0,022  Urate transporter 1 inhibitor
0,029  0,007  Lysophosphatidic acid 1 receptor antagonist
0,036  0,014  Uridine phosphorylase inhibitor
0,040  0,018  RNA-directed RNA polymerase inhibitor
0,026  0,004  Vitamin D receptor agonist
0,043  0,021  Cholesterol absorption inhibitor
0,027  0,006  Prostacyclin agonist
0,077  0,056  MAP kinase kinase 7 inhibitor
0,025  0,004  Lysophosphatidic acid receptor 3 agonist
0,030  0,009  Glutamate (mGluR1) agonist
0,028  0,008  ICAM 1 antagonist
0,035  0,015  GABA transporter 2 inhibitor
0,133  0,113  Cystic fibrosis treatment
0,093  0,073  Chronic obstructive bronchitis treatment
0,062  0,043  Prostaglandin F2 alpha antagonist
0,044  0,024  Hypogonadism treatment
0,038  0,019  Prostacyclin antagonist
0,048  0,029  Adenylate cyclase 1 inhibitor
0,037  0,018  Angiotensin II receptor antagonist
0,024  0,004  Thromboxane A2 agonist
0,056  0,037  Ribonucleoside-diphosphate reductase inhibitor
0,028  0,009  GRP78 expression inhibitor
0,042  0,023  AMPA 4 receptor antagonist
0,057  0,038  Ribonucleotide reductase inhibitor
0,060  0,041  Androgen agonist
0,057  0,039  Acetyl-CoA transferase 2 inhibitor
0,033  0,015  Endothelin receptor antagonist
0,023  0,005  Methylmalonyl-CoA mutase inhibitor
0,023  0,005  Telomerase stimulant
0,041  0,023  VCAM-1 antagonist
0,041  0,023  VCAM antagonist
0,029  0,012  Excitatory amino acid transporter 2 inhibitor
0,040  0,023  Factor XIIIa inhibitor
0,105  0,088  Antiviral (Hepatitis B)
0,036  0,019  Peroxisome proliferator-activated receptor delta antagonist
0,026  0,010  Integrin beta5 antagonist
0,049  0,033  HCV NS3/NS4A protease inhibitor
0,094  0,078  AMP-activated protein kinase stimulant
0,057  0,041  Lipocortins synthesis agonist
0,029  0,013  Thyroid hormone agonist
0,024  0,008  Free fatty acid receptor 1 agonist
0,092  0,077  Glutamate (mGluR7) agonist
0,039  0,024  Vanilloid 3 antagonist
0,024  0,009  Excitatory amino acid transporter 3 inhibitor
0,107  0,094  Tubulin antagonist
0,024  0,010  GABA transporter inhibitor
0,055  0,042  Xanthine dehydrogenase inhibitor
0,083  0,071  Potassium channel (Ca-activated) activator
0,024  0,012  Vitamin D receptor antagonist
0,040  0,029  Integrin alpha5beta1 antagonist
0,029  0,018  1,3-Beta-glucan synthase inhibitor
0,031  0,020  Glucagon receptor antagonist
0,033  0,022  Carboxypeptidase B inhibitor
0,084  0,073  Thioredoxin inhibitor
0,029  0,018  LFA antagonist
0,021  0,011  Caspase 8 inhibitor
0,054  0,044  Adenine nucleotide translocase inhibitor
0,029  0,019  Purinergic P2Y15 antagonist
0,014  0,005  Thromboxane agonist
0,028  0,019  Hypoxanthine phosphoribosyltransferase inhibitor
0,048  0,040  CD45 antagonist
0,129  0,121  CF transmembrane conductance regulator agonist
0,108  0,100  DNA repair enzyme inhibitor
0,016  0,009  GABA transporter 1 inhibitor
0,093  0,086  GABA receptor agonist
0,220  0,213  DNA directed DNA polymerase inhibitor
0,054  0,047  Botulinum neurotoxin type A inhibitor
0,010  0,005  Folate transporter 1 inhibitor
0,045  0,039  Carbonic anhydrase XIV inhibitor
0,035  0,030  Integrin alpha2 antagonist
0,069  0,064  SULT1A2 substrate
0,032  0,028  Phosphoglycerate kinase inhibitor
0,094  0,090  Adenylate cyclase inhibitor
0,035  0,031  Cholecystokinin B agonist
0,044  0,040  Estrogen agonist
0,067  0,063  Metalloproteinase-9 inhibitor
0,025  0,021  Integrin alpha2beta1 antagonist
0,052  0,048  Fatty acid synthase inhibitor
0,046  0,043  Squalene epoxidase inhibitor
0,024  0,020  Leukotriene D4 antagonist
0,018  0,015  Integrin beta3 antagonist
0,016  0,013  Excitatory amino acid transporter 1 inhibitor
0,016  0,014  Aminopeptidase A inhibitor
0,037  0,035  Thymidine kinase inhibitor
0,012  0,010  Carbonic anhydrase XI inhibitor
0,011  0,010  Integrin beta2 antagonist
0,014  0,013  Purinergic P2Y1 agonist
0,041  0,041  GP IIb/IIIa receptor antagonist
0,011  0,010  Calcium-dependent phospholipase A2 inhibitor
0,012  0,012  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,016  0,016  CXC chemokine 5 receptor antagonist

